| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Jun 24 | Jun 23 |
| Total Liabilities Shareholders' Equity | 841.35 | 794.20 | 794.36 | 1,101.19 |
| Accumulated Depreciation Total | -130.34 | -109.40 | -96.18 | -120.47 |
| Cash Equivalents | 99.74 | 89.81 | 149.77 | 339.63 |
| Other Liabilities Total | 56.15 | 37.12 | 30.33 | 37.52 |
| Accrued Expenses | 21.51 | 14.74 | 25.94 | 35.31 |
| Common Stock Total | 16.60 | 16.60 | 16.60 | 16.60 |
| Other Current Assets Total | 9.61 | 7.57 | 14.86 | 5.17 |
| Prepaid Expenses | 2.42 | 4.51 | 1.80 | 1.17 |
| Total Assets | 841.35 | 794.20 | 794.36 | 1,101.19 |
| Current Portof LT Debt/ Capital Leases | 3.57 | 2.81 | 2.68 | 3.12 |
| Additional Paid- In Capital | 11.13 | 11.13 | 11.13 | 11.13 |
| Cash | 77.50 | 92.27 | 88.73 | 95.42 |
| Total Equity | 524.55 | 536.96 | 538.24 | 750.89 |
| Long Term Investments | 2.51 | 4.37 | 1.90 | 2.25 |
| Retained Earnings( Accumulated Deficit) | 496.82 | 509.23 | 510.51 | 723.16 |
| Total Common Shares Outstanding | 1.66 | 1.66 | 1.66 | 1.66 |
| Property/ Plant/ Equipment Total- Gross | 243.17 | 231.39 | 227.71 | 293.74 |
| Tangible Book Valueper Share Common Eq | 315.72 | 323.05 | 323.67 | 451.79 |
| Total Liabilities | 316.80 | 257.24 | 256.12 | 350.30 |
| Total Debt | 9.29 | 7.62 | 9.56 | 12.00 |
| Cashand Short Term Investments | 177.24 | 182.08 | 251.87 | 447.61 |
| Total Receivables Net | 230.34 | 222.86 | 146.58 | 207.21 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 164.41 | 145.52 | 85.33 | 115.71 |
| Property/ Plant/ Equipment Total- Net | 112.83 | 121.99 | 131.53 | 173.27 |
| Total Current Liabilities | 254.93 | 215.31 | 218.91 | 303.90 |
| Total Inventory | 136.65 | 109.37 | 109.11 | 134.94 |
| Accounts Payable | 192.17 | 171.60 | 167.00 | 237.04 |
| Other Currentliabilities Total | 37.68 | 26.16 | 23.29 | 28.43 |
| Total Long Term Debt | 5.72 | 4.81 | 6.88 | 8.88 |
| Intangibles Net | 0.47 | 0.71 | 0.96 | 0.94 |
| Other Long Term Assets Total | 114.03 | 39.85 | 39.93 | 30.41 |
| Note Receivable- Long Term | 55.25 | 100.89 | 95.82 | 98.22 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 556.26 | 526.39 | 524.22 | 796.10 |
| Capital Lease Obligations | 5.72 | 4.81 | 6.88 | 8.88 |
| Short Term Investments | - | - | 13.37 | 12.56 |
Procter & Gamble Health Dividend Procter & Gamble Health Bonus Procter & Gamble Health News Procter & Gamble Health AGM Procter & Gamble Health Rights Procter & Gamble Health Splits Procter & Gamble Health Board Meetings Procter & Gamble Health Key Metrics Procter & Gamble Health Shareholdings Procter & Gamble Health Profit Loss Procter & Gamble Health Cashflow Procter & Gamble Health Q1 Results Procter & Gamble Health Q2 Results Procter & Gamble Health Q3 Results Procter & Gamble Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.